Aspira
Payments companies reported to CMS as associated with Aspira. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Aspira, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Aspira
These are the largest totals companies reported as associated with Aspira. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Chakravarthy Reddy | Salt Lake City, UT | Pulmonary Disease | $2,203.50 |
| Ali Sadoughi | Saint Louis, MO | Pulmonary Disease | $1,594.83 |
| Peter Hathaway | Farmington, UT | Vascular & Interventional Radiology | $1,593.75 |
| Jonathan Kurman | Milwaukee, WI | Pulmonary Disease | $1,425.00 |
| Deepankar Sharma | Columbus, IN | Pulmonary Disease | $237.50 |
| Brian Ching | Tripler Army Medical Center, HI | Vascular & Interventional Radiology | $115.98 |
| Roger Williams | Marietta, GA | Vascular & Interventional Radiology | $112.48 |
| John Lipman | Smyrna, GA | Vascular & Interventional Radiology | $112.48 |
| Glenn Kerwin | Marietta, GA | Vascular & Interventional Radiology | $112.48 |
| Nathan Ertel | Marietta, GA | Vascular & Interventional Radiology | $112.48 |
Prescribed Aspira?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.